Two Sigma Advisers’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Two Sigma Advisers’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,200	Closed	-$722K	–	2390
2024 Q3	$722K	Buy	4,200 +200	+5%	+$33.1K	﹤0.01%	1554
2024 Q2	$616K	Sell	4,000 -3,100	-44%	-$465K	﹤0.01%	1793
2024 Q1	$1.09M	Buy	7,100 +2,700	+61%	+$412K	﹤0.01%	1545
2023 Q4	$695K	Sell	4,400 -3,000	-41%	-$431K	﹤0.01%	1788
2023 Q3	$1.08M	Sell	7,400 -2,800	-27%	-$427K	﹤0.01%	1487
2023 Q2	$1.56M	Buy	10,200 +300	+3%	+$46.8K	﹤0.01%	1330
2023 Q1	$1.53M	Buy	9,900 +6,700	+209%	+$1.05M	﹤0.01%	1410
2022 Q4	$493K	Sell	3,200 -2,500	-44%	-$369K	﹤0.01%	1881
2022 Q3	$752K	Buy	+5,700	New	+$800K	﹤0.01%	1670

Other funds holding FBT

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Two Sigma Advisers's FBT Position: Q4 2024 in Review

Two Sigma Advisers sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2024, closing a stake of 4,200 shares — an estimated $722K sold.

Two Sigma Advisers first reported a position in FBT in Q3 2022 and held it in 9 quarters. The position peaked at $1.56M in Q2 2023. 256 funds tracked by Wall St. Rank hold FBT as of Q4 2024.

Two Sigma Advisers reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2024 after selling out during the quarter.
Two Sigma Advisers sold 4,200 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2024, an estimated $722K.
Two Sigma Advisers first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2022 and held it in 9 quarters.
Two Sigma Advisers's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.56M in Q2 2023.
256 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.